Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:791602.
doi: 10.1155/2012/791602. Epub 2012 Oct 23.

Radiographically negative, asymptomatic, sentinel lymph node positive cutaneous T-cell lymphoma in a 3-year-old male: a case report

Affiliations

Radiographically negative, asymptomatic, sentinel lymph node positive cutaneous T-cell lymphoma in a 3-year-old male: a case report

Jeffrey Carson et al. Case Rep Pediatr. 2012.

Abstract

We present a case of a 3-year-old male originally diagnosed with a CD30+ anaplastic cutaneous T-cell lymphoma with no evidence of systemic disease after CT scan, PET scan, and bone marrow aspiration. Sentinel lymph node biopsy (SLNB) was performed as an additional step in the workup and showed microscopic disease. Current management/recommendations for cutaneous T-cell lymphoma do not include SLNB. Medical and surgical management of cutaneous malignancies is dramatically different for local versus advanced disease. Therefore adequate evaluation is necessary to properly stage patients for specific treatment. Such distinction in extent of disease suggests more extensive therapy including locoregional radiation and systemic chemotherapy versus local excision only. Two international case reports have described SLNB in cutaneous T-cell lymphoma with one demonstrating evidence of node positive microscopic disease despite a negative metastatic disease workup. This case is being presented as a novel case in a child with implications including lymphoscintigraphy and SLNB as a routine procedure for evaluation and staging of cutaneous T-cell lymphoma if the patient does not demonstrate evidence of metastatic disease on routine workup.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lymphoscintigraphy demonstrating uptake in the right axilla.
Figure 2
Figure 2
One of the “blue/hot” lymph nodes being removed from the right axilla.
Figure 3
Figure 3
ALK-1 immunohistochemistry of sentinel lymph node demonstrating metastatic cells.
Figure 4
Figure 4
CD30 immunohistochemistry of sentinel node demonstrating metastatic cells.

References

    1. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis: a European multicenter study of 47 patients. Cancer. 1993;71(6):2097–2104. - PubMed
    1. Lansigan F, Foss FM. Current and emerging treatment strategies for cutaneousT-cell lymphoma. Drugs. 2010;70(3):273–286. - PubMed
    1. Krämer KU, Starz H, Balda BR. Primary cutaneous CD30-positive large T-cell lymphoma with secondary lymph node involvement detected by sentinel lymphonodectomy. Acta Dermato-Venereologica. 2002;82(1):73–74. - PubMed
    1. Krishnan J, Tomaszewski MM, Kao GF. Primary cutaneous CD30-positive anaplastic large cell iymphoma. Report of 27 cases. Journal of Cutaneous Pathology. 1993;20(3):193–202. - PubMed
    1. Kadin ME. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders. Oncology. 2009;23(13):1158–1164. - PubMed

LinkOut - more resources